Open AccessMultimodality of pharmacological brain protection as a basis for successful therapy in angioneurology
Author(s) -
S.H. Burchynskyi
Publication year - 2021
Publication title -
meždunarodnyj nevrologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2307-1419
pISSN - 2224-0713
DOI - 10.22141/2224-0713.17.4.2021.237602
Subject(s) - neuroprotection , citicoline , medicine , action (physics) , neuroscience , intensive care medicine , pharmacology , psychology , physics , quantum mechanics
Combined neuroprotection is currently a global trend in neurological practice. In this article, the author proposes to focus on neuroprotective drugs that affect the fundamental, leading mechanisms in the development of cerebrovascular pathology and that are a clear example of the possibility of successful use of an effective combination of these drugs in the treatment of a particular disease in a particular patient. The best option for choosing instruments of combined neuroprotection is citicoline and ethyl-methyl-hydroxypyridine succinate. In addition to complementary mechanisms of action, this combination of drugs is characterized by synergism in the development of therapeutic effects, i.e. not just summation, but mutual strengthening of the action of each of the components of the combination.